ISIDORe II Integrated Services for Infectious Disease Outbreak Research Ii
- Coordinator
- European Research Infrastructure on Highly Pathogenic Agents, Belgium
- Runs
- 1 June 2026 to 31 May 2029
- Status
- Running
- EU funding
- €10.5m
- Total cost
- €10.5m
- Partners
- 56 organisations in 20 countries
- Type
- Research and Innovation Action
- Grant agreement
- 101293306
What the project is doing
In the project's own words, from its summary on CORDIS.
ISIDORe II (Integrated Services for Infectious Disease Outbreak Research II) represents the strategic continuation of ISIDORe. Building on its proven capacity to mobilise Europe’s research infrastructures (RIs) for pandemic preparedness and response (PP&R) research, ISIDORe II consolidates the model into a leaner, strategically aligned consortium that enhances agility, coherence, and sustainability. Infectious disease–focused RIs form the operational backbone, ensuring depth in epidemic- and pandemic-relevant science, while transversal RIs provide enabling technologies such as imaging, omics, and structural biology.
This integrated architecture ensures that Europe’s RI landscape delivers high-quality, challenge-driven, and interoperable services. ISIDORe II pursues three overarching missions: (1) deliver excellent RI services for PP&R research and empower users through a curated service catalogue, an interoperable digital platform, and inclusive outreach; (2) amplify impact by enabling scientific excellence, innovation, and data stewardship, accelerating medical countermeasure (MCM) development, embedding FAIR principles, and aligning with European Open Science policies; and (3) anchor the ISIDORe model within the EU and global preparedness ecosystem through coordination with actors such as HERA, ECDC, WHO, and DURABLE, while developing a stakeholder-validated sustainability plan.
By offering a coherent, strategically sharpened model for transnational and virtual access (TNA/VA), ISIDORe II ensures that users benefit from comprehensive support, including ethics, biosafety, and regulatory guidance, alongside interoperable data practices. Its activities generate scientific excellence, policy-relevant evidence, and long-term impact for European and global health security. As the natural continuation of ISIDORe, ISIDORe II transforms a successful pilot into a sustainable cornerstone of the European preparedness and response landscape.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| European Research Infrastructure on Highly Pathogenic Agents | Bruxelles / Brussel | Belgium | Coordinator |
| Biobanks and Biomolecular Resources Research Infrastructure Consortium (bbmri-Eric) | Graz | Austria | Participant |
| Medizinische Universitat Graz | Graz | Austria | Third party |
| European Virus Archive Aisbl | Ixelles | Belgium | Participant |
| Katholieke Universiteit Leuven | Leuven | Belgium | Third party |
| Eidgenoessisches Departement Des Innern | Bern | Switzerland | Participant |
| Vaccine Formulation Institute(ch)ltd | Plan Les Ouates | Switzerland | Participant |
| Ceske Vysoke Uceni Technicke V Praze | Praha | Czechia | Third party |
| Ustav Molekularni Genetiky Av Cr V.v.i. | Praha 4 | Czechia | Third party |
| Bernhard-Nocht-Institut Fuer Tropenmedizin | Hamburg | Germany | Third party |
| Charite - Universitaetsmedizin Berlin | Berlin | Germany | Third party |
| European Infrastructure of Open Screening Platforms for Chemical Biology European Research Infrastucture Consortium (eu-Openscreen Eric) | Berlin | Germany | Participant |
| European Molecular Biology Laboratory | Heidelberg | Germany | Participant |
| European Vaccine Initiative eV | Heidelberg | Germany | Participant |
| Friedrich Loeffler Institut - Bundesforschungsinstitut Fuer Tiergesundheit | Greifswald-Insel Riems | Germany | Participant |
| Helmholtz-Zentrum Fur Infektionsforschung GmbH | Braunschweig | Germany | Participant |
| Infrafrontier Eric | Neuherberg | Germany | Participant |
| Statens Serum Institut | Kobenhavn S | Denmark | Participant |
| Hellenic Pasteur Institute | Athens | Greece | Third party |
| Agencia Estatal Consejo Superior De Investigaciones Cientificas | Madrid | Spain | Third party |
| Fundacion Centro De Excelencia En Investigacion De Medicamentos Innovadores En Andalucia | Armilla Granada | Spain | Third party |
| Institut De Investigacio En Ciencies De La Salut Germans Trias I Pujol | Badalona Barcelona | Spain | Third party |
| Institut De Recerca I Tecnologia Agroalimentaries | Caldes De Montbui Barcelona | Spain | Participant |
| Euro-Bioimaging Eric | Turku | Finland | Participant |
| Helsingin Yliopisto | Helsinki | Finland | Third party |
| Assistance Publique Hopitaux De Paris | Paris | France | Participant |
| Centre National De La Recherche Scientifique CNRS | Paris | France | Third party |
| Ecrin European Clinical Research Infrastructure Network | Paris | France | Participant |
| Institut National De La Sante Et De La Recherche Medicale | Paris | France | Third party |
| Institut National De Recherche Pour L'agriculture, L'alimentation Et L'environnement | Paris | France | Participant |
| Institut Pasteur | Paris | France | Third party |
| Mediterranee Infection | Marseille | France | Participant |
| Universite D'aix Marseille | Marseille | France | Third party |
| Nemzeti Nepegeszsegugyi Es Gyogyszereszeti Kozpont | Budapest | Hungary | Third party |
| Consiglio Nazionale Delle Ricerche | Roma | Italy | Third party |
| Istituto Nazionale per Le Malattie Infettive Lazzaro Spallanzani-Istituto Di Ricovero E Cura a Carattere Scientifico | Roma | Italy | Third party |
| Istituto Superiore Di Sanita | Roma | Italy | Third party |
| Istituto Zooprofilattico Sperimentale Della Lombardia E Dell'emilia Romagna Bruno Ubertini | Brescia | Italy | Third party |
| Istituto Zooprofilattico Sperimentale Delle Venezie | Legnaro | Italy | Third party |
| Valsts zinatniskais instituts ""Nacionalais petniecibas un inovaciju instituts"""" | Riga | Latvia | Third party |
| Eatris Eric | Amsterdam | Netherlands | Participant |
| Erasmus Universitair Medisch Centrum Rotterdam | Rotterdam | Netherlands | Third party |
| Rijksinstituut Voor Volksgezondheid En Milieu (rivm) | Bilthoven | Netherlands | Third party |
| Stichting Biomedical Primate Research Center | Rijswijk Zh | Netherlands | Participant |
| Stichting Wageningen Research | Wageningen | Netherlands | Participant |
| Universitetet I Tromsoe - Norges Arktiske Universitet | Tromso | Norway | Third party |
| Fundacao Gimm - Gulbenkian Institute for Molecular Medicine | Lisboa | Portugal | Third party |
| Instituto De Biologia Experimental E Tecnologica | Oeiras | Portugal | Participant |
| Instituto Nacional De Saude Dr. Ricardo Jorge | Lisboa | Portugal | Third party |
| Folkhalsomyndigheten | Solna | Sweden | Third party |
| Karolinska Institutet | Stockholm | Sweden | Third party |
| Univerza V Ljubljani | Ljubljana | Slovenia | Third party |
| Biomedicinske Centrum Slovenskej Akademie Vied, Verejna Vyskumna Institucia | Bratislava | Slovakia | Third party |
| Department of Health | Leeds | United Kingdom | Third party |
| Instruct-Eric | Oxford | United Kingdom | Participant |
| The Chancellor, Masters and Scholars of the University of Oxford | Oxford | United Kingdom | Third party |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI